TEVA PHARMACEUTICAL INDUSTRIES LIMITED AND THE BANK OF NEW YORK As Depositary AND OWNERS AND HOLDERS OF AMERICAN DEPOSITARY RECEIPTS Deposit Agreement Dated as of February 8, 1982 as amended on September 29, 1986, August 28, 1987, March 13, 1990,...Deposit Agreement • October 6th, 2005 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations • New York
DEPOSIT AGREEMENT dated as of February 8, 1982, as amended on September 29, 1986, August 28, 1987, March 13, 1990, March 6, 1992, March 5, 1993 and April 13, 1993, as further amended and restated as of February 12, 19971997, and as further amended and restated as of ________________, 2005, among TEVA PHARMACEUTICAL INDUSTRIES LIMITED, incorporated under the laws of Israel (herein called the Issuer), THE BANK OF NEW YORK, a New York banking corporation (herein called the Depositary), and all Owners and holders from time to time of American Depositary Receipts issued hereunder.
Exhibit A to Deposit AgreementDeposit Agreement • October 6th, 2005 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
representing deposited fully-paid Ordinary Shares (herein called "Shares") of Teva Pharmaceutical Industries Limited, incorporated under the laws of Israel (herein called the "Company"). At the date hereof, each American Depositary Share represents one (1) Share deposited under the deposit agreement at the principal Tel Aviv office of Bank Leumi Le-Israel Ltd. or the principal Tel Aviv office of Israel Discount Bank Limited (herein each called a "Custodian"). The Depositary's Corporate Trust Office is located at a different address than its principal executive office. Its Corporate Trust Office is located at 101 Barclay Street, New York, N.Y. 10286, and its principal executive office is located at One Wall Street, New York, N.Y. 10286.
ContractDeposit Agreement • October 6th, 2005 • Teva Pharmaceutical Industries LTD • Pharmaceutical preparations
Re: Amended and Restated Deposit Agreement dated as of ___________, 2005 (the "Deposit Agreement") by and among Teva Pharmaceutical Industries Limited (the “Company”), The Bank of New York, as Depositary, and the Owners and holders of American Depositary Receipts
